Dcpp v. J v. and A.A., in the Matter of W.A.

New Jersey Superior Court Appellate Division·Decided September 5, 2024·No. A-3215-21·Unpublished

Opinion

RECORD IMPOUNDED

NOT FOR PUBLICATION WITHOUT THE APPROVAL OF THE APPELLATE DIVISION This opinion shall not "constitute precedent or be binding upon any court ." Although it is posted on the internet, this opinion is binding only on the parties in the case and its use in other cases is limited. R. 1:36-3.

SUPERIOR COURT OF NEW JERSEY APPELLATE DIVISION

DOCKET NO. A-3215-21

NEW JERSEY DIVISION OF CHILD PROTECTION AND PERMANENCY,

Plaintiff-Respondent,

v. J.V., Defendant-Appellant,

and A.A.,

Defendant.

IN THE MATTER OF W.A., a minor.

Submitted March 20, 2024 – Decided September 5, 2024 Before Judges Vernoia and Gummer.

On appeal from the Superior Court of New Jersey, Chancery Division, Family Part, Passaic County, Docket No. FN-16-0057-21.

Jennifer Nicole Sellitti, Public Defender, attorney for appellant (Richard Foster, Deputy Public Defender, of counsel and on the briefs).

Matthew J. Platkin, Attorney General, attorney for respondent (Sara Gregory, Assistant Attorney General, of counsel; Lisa J. Rusciano, Deputy Attorney General, on the brief).

Jennifer Nicole Sellitti, Public Defender, Law Guardian, attorney for minor (Meredith Alexis Pollock, Deputy Public Defender, of counsel; Linda Vele Alexander, Designated Counsel, on the brief).

PER CURIAM Defendant J.V. appeals from a February 22, 2022 Family Part order finding she abused or neglected her daughter W.A, who was born in September 2020, by using marijuana, cocaine, and unprescribed Percocet while pregnant with the child and by causing actual harm to W.A., who tested positive for marijuana and opiates when she was born, "was diagnosed with neonatal abstinence syndrome (NAS), required extended hospitalization, and had to be administered morphine to treat her withdrawal symptoms."1 Defendant also

1 We use initials to refer to W.A., her mother, defendant J.V., and her father, A.A., to protect the child's privacy and because records related to New Jersey

A-3215-21

appeals from a May 10, 2022 order dismissing the Title Nine proceeding following the Division's filing of a guardianship complaint seeking termination of defendant's parental rights to W.A. Based on our review of the record and the parties' arguments, we vacate the orders and remand for further proceedings and for the court to issue new findings on the Division's claim defendant abused or neglected W.A.

I.

Immediately following W.A.'s birth at Hackensack Medical Center, a hospital representative contacted the Division's Special Response Unit (SPRU) and made a referral regarding W.A. A screening summary report—completed by the SPRU and later admitted into evidence at the fact-finding hearing on the Division's complaint alleging defendant had abused or neglected W.A.—states a hospital representative had reported that defendant had limited prenatal care and had tested positive for marijuana, cocaine, and opiates, and that W.A. had been born at thirty-eight-weeks-gestation, weighing four pounds and twelve- and-four-tenths ounces. The screening summary reflects that the Division had

Division of Child Protection and Permanency (the Division) proceedings held pursuant to Rule 5:12 are excluded from public access under Rule 1:38-3(d)(12).

A-3215-21

coded the referral as "Substance Abuse of Caregiver Threatens Child; Substance Affected Newborn."

According to a Division investigation summary report, which was admitted into evidence at the fact-finding hearing, Division caseworker Samantha Hicks reported that she had been advised by hospital staff that they were awaiting a toxicology screen for W.A. Hicks spoke with a hospital nurse who stated defendant had reported that she tested positive for THC, cocaine, and opiates during a July 2020 visit with a prenatal doctor.2 Hicks also spoke with defendant, who admitted she had been using marijuana and oxycontin during the last four months of her pregnancy and "was using cocaine from time to time" but had not used it recently. Defendant told Hicks she had used oxycodone to address back-pain issues during the last four months of the pregnancy; she had been taking oxycodone twice per day; and she had obtained the oxycodone "off the streets" because she had been unsuccessful in obtaining a prescription from a doctor. Hicks also reported that on September

2 THC, or delta-9-tetrahydrocannabinol, "is believed to be the main ingredient that produces the psychoactive effect" in marijuana. Drug Enf't Admin., Marijuana/Cannabis (Oct. 2022), https://www.dea.gov/sites/default/files/2023- 03/Marijuana-Cannabis%202022%20Drug%20Fact%20Sheet.pdf; see also Merriam-Webster's Online Dictionary, https://www.merriamwebster .com/dictionary/THC (last visited Aug. 27, 2024) (THC is "the chief intoxicant in marijuana").

A-3215-21

20, 2020, she was advised by the hospital that W.A. had tested positive for THC and opiates, had started experiencing withdrawal symptoms on September 19, 2020, and had been transferred to the neonatal intensive care unit (NICU). Defendant was discharged from the hospital, but W.A. remained in the hospital for further observation.

The investigation summary report further showed that on September 22, 2020, Division caseworker Diane Irene interviewed defendant at defendant's home. During the interview, Irene informed defendant she had tested positive for marijuana, cocaine, and opiates, and W.A. had tested positive for marijuana and opiates, "which . . . caused withdrawal symptoms" for W.A. Irene also reported that defendant said she had a prescription for oxycodone, but the prescription had been issued two days after W.A.'s birth. According to Irene's report, defendant stated she had last used cocaine in June 2020, and she had used marijuana throughout her pregnancy.

The Division's investigation summary report further details information concerning W.A. that Irene received from various hospital staff in September. The investigation summary report states that during her hospital stay, W.A. was gradually weaned off morphine as her withdrawal symptoms, as measured by NAS testing, improved until her discharge in late September. Hospital staff also

A-3215-21

reported to Irene that at various times during W.A.'s hospitalization, the child had been observed to "appear[] inconsolable," had "twitch[ed]," and had "tight muscle tone" after she was taken off morphine. The hospital also reported to Irene that a test of W.A.'s "meconium levels" had been "presumptively positive for THC and opiates."

In late September, the hospital discharged W.A. to defendant's care subject to defendant's agreement to a Division safety action plan requiring that defendant's sister supervise defendant's interactions with W.A. The Division also required that defendant undergo weekly random urine screens, but defendant missed many of the screens, tested positive for various drugs at an October 14, 2020 urine screen, and agreed to undergo substance-abuse treatment. Defendant did not participate in the treatment sessions and again tested positive for various drugs on October 21, 2020.

On November 10, 2020, the Division filed a complaint seeking an order for care and supervision of W.A. based on defendant's positive drug screen results and failure to submit to drug screens and attend substance-abuse treatment. At a December 8, 2020 hearing on the complaint, the Division explained that it sought an order for care and supervision of W.A. because of her "medical fragility" at birth and her parents' substance-abuse issues, and

A-3215-21

because W.A. was at imminent risk of harm. Defendant's counsel represented that defendant would comply with the Division's services moving forward.

The court awarded the Division care and supervision of W.A., explaining defendant had continued to test positive for illicit drugs and the Division had made a prima facie showing that W.A. had been "abused and neglected within the meaning of N.J.S.A. 9:6-8.21." The court entered an order granting the Division care and supervision of W.A.

Free access — add to your briefcase to read the full text and ask questions with AI

Dcpp v. J v. and A.A., in the Matter of W.A., (N.J. Ct. App. 2024).

Dcpp v. J v. and A.A., in the Matter of W.A. (Dcpp v. J v. and A.A., in the Matter of W.A.) — published by Counsel Stack Legal Research, free access to 12M+ legal documents.

Related

New Jersey Div. of Youth & Family Serv. v. Jy
800 A.2d 132 (New Jersey Superior Court App Division, 2002)
New Jersey Division of Youth & Family Services v. E.P.
952 A.2d 436 (Supreme Court of New Jersey, 2008)
New Jersey Dyfs v. Bh
918 A.2d 63 (New Jersey Superior Court App Division, 2007)
Cesare v. Cesare
713 A.2d 390 (Supreme Court of New Jersey, 1998)
State v. Locurto
724 A.2d 234 (Supreme Court of New Jersey, 1999)
Hahnemann Univ. Hosp. v. Dudnick
678 A.2d 266 (New Jersey Superior Court App Division, 1996)
Brett v. Great American Recreation, Inc.
677 A.2d 705 (Supreme Court of New Jersey, 1996)
Brun v. Cardoso
915 A.2d 1053 (New Jersey Superior Court App Division, 2006)
In Re Cope
255 A.2d 798 (New Jersey Superior Court App Division, 1969)
Nieder v. Royal Indemnity Insurance
300 A.2d 142 (Supreme Court of New Jersey, 2004)
Div. of Youth & Fam. Svcs. v. Vt
32 A.3d 578 (New Jersey Superior Court App Division, 2011)
New Jersey Division of Youth & Family Services v. M.M.
914 A.2d 1265 (Supreme Court of New Jersey, 2007)
New Jersey Division of Youth & Family Services v. P.W.R.
11 A.3d 844 (Supreme Court of New Jersey, 2011)
Department of Children & Families v. E.D.-o.
121 A.3d 832 (Supreme Court of New Jersey, 2015)
New Jersey Division of Child Protection and Permanency
139 A.3d 108 (New Jersey Superior Court App Division, 2016)
New Jersey Division of Child Protection and Permanency
148 A.3d 128 (New Jersey Superior Court App Division, 2016)
New Jersey Division of Child Protection and Permanency
151 A.3d 985 (New Jersey Superior Court App Division, 2016)
New Jersey Division of Youth & Family Services v. B.M. & T.B.
993 A.2d 258 (New Jersey Superior Court App Division, 2010)